Adbiotech Co. Ltd.
ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea.
Adbiotech Co. Ltd. (179530) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 39.282x
Based on the latest financial reports, Adbiotech Co. Ltd. (179530) has a cash flow conversion efficiency ratio of 39.282x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩567.31 Million) by net assets (₩14.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Adbiotech Co. Ltd. - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Adbiotech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Adbiotech Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adbiotech Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grolleau SAS
PA:ALGRO
|
0.045x |
|
GROLLEAU SAS EO -5
F:30U
|
N/A |
|
Ease2pay NV
AS:EAS2P
|
0.044x |
|
Gujarat Apollo Industries Limited
NSE:GUJAPOLLO
|
-0.009x |
|
NamSys Inc
PINK:NMYSF
|
0.031x |
|
M VEST WATER NK-00227652
F:7YA
|
N/A |
|
COMTEC SOLAR SYS HD -004
F:8C11
|
N/A |
|
T-Conn Precision Corporation
TWO:6833
|
-0.172x |
Annual Cash Flow Conversion Efficiency for Adbiotech Co. Ltd. (2014–2024)
The table below shows the annual cash flow conversion efficiency of Adbiotech Co. Ltd. from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩4.84 Billion | ₩-4.09 Billion | -0.846x | -3013.81% |
| 2023-12-31 | ₩10.85 Billion | ₩314.93 Million | 0.029x | +105.47% |
| 2022-12-31 | ₩16.19 Billion | ₩-8.59 Billion | -0.531x | -25.39% |
| 2021-12-31 | ₩5.11 Billion | ₩-2.16 Billion | -0.423x | -287.41% |
| 2020-12-31 | ₩9.33 Billion | ₩-1.02 Billion | -0.109x | -924.42% |
| 2019-12-31 | ₩6.99 Billion | ₩-74.54 Million | -0.011x | -140.70% |
| 2018-12-31 | ₩4.53 Billion | ₩118.60 Million | 0.026x | -77.33% |
| 2017-12-31 | ₩4.60 Billion | ₩531.78 Million | 0.116x | +155.84% |
| 2014-12-31 | ₩3.15 Billion | ₩-652.82 Million | -0.207x | -- |